BRUGNOLO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 12.521
NA - Nord America 2.327
AS - Asia 1.514
Continente sconosciuto - Info sul continente non disponibili 160
SA - Sud America 149
AF - Africa 38
OC - Oceania 2
Totale 16.711
Nazione #
IT - Italia 12.250
US - Stati Uniti d'America 2.194
SG - Singapore 590
CN - Cina 361
VN - Vietnam 262
BD - Bangladesh 137
FR - Francia 99
BR - Brasile 82
CA - Canada 63
HK - Hong Kong 44
GB - Regno Unito 36
DE - Germania 32
AR - Argentina 23
FI - Finlandia 23
JP - Giappone 20
IN - India 16
IQ - Iraq 15
JM - Giamaica 15
ID - Indonesia 14
MX - Messico 14
CH - Svizzera 12
CR - Costa Rica 12
EC - Ecuador 12
CO - Colombia 11
NL - Olanda 11
PL - Polonia 11
ES - Italia 10
PK - Pakistan 8
IE - Irlanda 7
ZA - Sudafrica 7
EG - Egitto 6
PH - Filippine 6
RU - Federazione Russa 6
TR - Turchia 6
UA - Ucraina 6
DZ - Algeria 5
MA - Marocco 5
TH - Thailandia 5
TW - Taiwan 5
VE - Venezuela 5
BS - Bahamas 4
CL - Cile 4
HN - Honduras 4
KE - Kenya 4
SV - El Salvador 4
AL - Albania 3
BO - Bolivia 3
NI - Nicaragua 3
PR - Porto Rico 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BB - Barbados 2
BE - Belgio 2
GD - Grenada 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
LC - Santa Lucia 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SC - Seychelles 2
SE - Svezia 2
TT - Trinidad e Tobago 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LR - Liberia 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
VI - Stati Uniti Isole Vergini 1
Totale 16.551
Città #
Genova 6.358
Genoa 3.468
Rapallo 1.189
Vado Ligure 913
San Jose 435
Singapore 299
Ashburn 248
Ho Chi Minh City 95
Lauterbourg 78
New York 64
Beijing 62
Hanoi 58
Los Angeles 54
Santa Clara 51
Dallas 50
Hong Kong 39
Bordighera 34
Rome 34
Atlanta 28
Milan 28
Frankfurt am Main 26
Helsinki 23
Chicago 22
Orem 19
Montreal 17
Phoenix 17
Tokyo 17
Brooklyn 14
Denver 14
Toronto 14
Houston 12
Council Bluffs 11
Seattle 11
Zurich 11
Philadelphia 10
San Francisco 10
São Paulo 10
Bologna 9
Buffalo 9
Detroit 9
London 9
Mexico City 9
Naples 9
San José 9
Tianjin 9
Warsaw 9
Cleveland 8
Miami 8
Washington 8
Da Nang 7
Kingston 7
Palermo 7
Paris 7
Boston 6
Brasília 6
Dublin 6
Florence 6
Hải Dương 6
Jakarta 6
Madrid 6
Turin 6
Amsterdam 5
Belo Horizonte 5
Haiphong 5
Jacksonville 5
Phủ Lý 5
Pittsburgh 5
Aurora 4
Baghdad 4
Bogotá 4
Brescia 4
Cairo 4
Cardiff 4
Charlotte 4
Chennai 4
Douglasville 4
El Paso 4
Fort Myers 4
Guayaquil 4
Johannesburg 4
Las Vegas 4
Louisville 4
Nassau 4
North Bergen 4
Oklahoma City 4
Polistena 4
Staten Island 4
Taranto 4
Thái Nguyên 4
Wilmington 4
Allen 3
Alpharetta 3
Casalgrande 3
Changsha 3
Cincinnati 3
City of London 3
Columbus 3
Erie 3
Greensboro 3
Hoover 3
Totale 14.176
Nome #
Personality traits and levels of anxiety and depression among martial artists: a cross-sectional study 827
An updated Italian normative dataset for the Stroop color word test (SCWT) 283
A normative study of the Italian printed word version of the free and cued selective reminding test 240
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 224
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 220
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 219
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 217
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 208
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 202
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 200
Parkinson’s Disease Sleep Scale 2: application in an Italian population 199
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 198
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 188
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 187
Cortical sources of awake scalp EEG in eating disorders 184
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 183
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 182
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 181
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 180
Early identification of MCI converting to AD: a FDG PET study 177
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 175
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 174
What predicts cognitive decline in de novo Parkinson's disease? 171
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 170
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 170
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 169
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 169
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 168
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 167
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 163
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 163
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 160
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 160
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 159
How can we define a brain health chart? A narrative review and a proposal 157
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 157
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 157
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 157
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 156
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 156
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 154
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 154
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 154
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 154
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 154
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 150
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 150
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 150
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 149
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 149
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 147
The Von Restorff effect in ageing and Alzheimer's disease. 147
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 146
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 145
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 144
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 142
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 141
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 138
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 138
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 137
Do we need a 99mTc-ECD template for SPM SPECT studies? 136
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 135
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 134
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 132
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 131
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 131
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 130
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 130
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 130
MMSE factorial analysis in Alzheimer’s disease. 129
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 129
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 128
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 128
Principal component analysis of FDG PET in amnestic MCI 127
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 127
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 127
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 125
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 124
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 121
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 121
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 120
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 120
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 120
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 119
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 114
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 114
Principal component analysis of FDG PET in amnestic MCI 114
Cortical sources of awakening scalp EEG in eating disorders. 111
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 111
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 110
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 110
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 109
The need of appropriate brain spect templates for spm comparisons 107
Cognitive impairment assessment through handwriting (COGITAT) score: a novel tool that predicts cognitive state from handwriting for forensic and clinical applications 106
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 106
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 105
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 104
Is Euro a cognitive chellenge for the elderly? 103
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 103
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 102
Totale 15.703
Categoria #
all - tutte 53.480
article - articoli 42.912
book - libri 0
conference - conferenze 9.772
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 796
Totale 106.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.128 0 0 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20252.335 82 164 52 160 277 280 230 358 111 114 247 260
2025/20264.101 557 141 211 304 501 297 612 219 370 383 262 244
2026/20271.664 986 338 340 0 0 0 0 0 0 0 0 0
Totale 16.711